0 CHECKOUT

Kenya Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3456712
  • November 2015
  • Region: Kenya
  • 82 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi
  • MORE

While Kenya's underdeveloped healthcare infrastructure is not conducive to clinical trials (only 14 clinical trials were registered in 2014), the country, as with other markets in the region, can offer numerous benefits to drugmakers looking to conduct clinical trials - including access to large, treatmentnaïve populations. This industry notes that this feature is vital in clinical trials as it reduces data variability.

Furthermore, Africa has the world's highest population of HIV-positive patients and has a high burden of communicable diseases. With the vaccine industry experiencing rejuvenation through globally-funded alliances, providing cheaper immunisation programmes for developing countries, conducting clinical trials in selected sub-populations such as those in Kenya will become increasingly important.

Headline Expenditure Projections
- Pharmaceuticals: KES63.75bn (USD725mn) in 2014 to KES73.74bn (USD742mn) in 2015; 15.1%
growth in local currency terms and 2.4% in US dollar terms.

- Healthcare: KES190.42bn (USD2.17bn) in 2014 to KES213.03bn (USD2.16bn) in 2015; 11.9% growth in local currency terms and -0.4% in US dollar terms.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi
  • MORE

Table: Headline Pharmaceuticals & Healthcare Forecasts (Kenya 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kenya 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kenya 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kenya 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kenya 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kenya 2011-2019)

OTC Medicines Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kenya 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Kenya 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Kenya 2013-2019)

Industry Risk Reward Index

Middle East and Africa Risk/Reward Index - Q1 2016

Kenya Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Issues

Pricing & Reimbursement Regime

Market Overview

Healthcare Sector
Table: Healthcare Resources (Kenya 2009-2014)
Table: Healthcare Personnel (Kenya 2009-2014)
Table: Healthcare Activity (Kenya 2009-2014)

Research & Development

Clinical Trials

Epidemiology

Competitive Landscape

Research-Based Industry
Table: Multinational Market Activity

Pharmaceutical Distribution

Pharmaceutical Retail Sector

Company Profile

GlaxoSmithKline

Merck & Co

Novartis

Pfizer

Sanofi

Demographic Forecast
Table: Population Headline Indicators (Kenya 1990-2025)
Table: Key Population Ratios (Kenya 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Kenya 1990-2025)
Table: Population By Age Group (Kenya 1990-2025)
Table: Population By Age Group % (Kenya 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

GlaxoSmithKline
Merck & Co
Novartis
Pfizer
Sanofi

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.